Filing Details
- Accession Number:
- 0001127602-18-000574
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-03 16:09:36
- Reporting Period:
- 2018-01-02
- Accepted Time:
- 2018-01-03 16:09:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1000697 | Waters Corp | WAT | Laboratory Analytical Instruments (3826) | 133668640 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1186877 | J Michael Berendt | 34 Maple Street Milford MA 01757 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-02 | 3,500 | $76.75 | 26,849 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-02 | 3,500 | $194.58 | 23,349 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-01-02 | 562 | $0.00 | 23,911 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-01-02 | 3,500 | $0.00 | 3,500 | $76.75 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-01-02 | 2,692 | $0.00 | 2,692 | $195.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-01-02 | 2018-01-02 | No | 4 | M | Direct |
| 2,692 | 2019-01-02 | 2028-01-02 | No | 4 | A | Direct |
Footnotes
- Acquisition of common stock was made under a sale plan established pursuant to the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Sale of common stock was made under a sale plan established pursuant to the requirements of Rule 10b5-1 under the Securities and Exchange Act of 1934, as amended.
- Grant of shares of common stock subject to restrictions that lapse January 2, 2019.
- Options fully vest on January 2, 2019.
Billionaire Hedge Funds
